Devices, diagnostics, wearables
5 stories
Glaukos Corporation and Talkspace, Inc. reported strong Q4 2025 financial results, highlighting a successful transition toward high-margin, recurring revenue models. Glaukos saw significant gains from its iDose TR launch, while Talkspace solidified its position as a profitable, payer-led behavioral health leader.
Maverick Simulation Solutions has unveiled a high-fidelity infant training mannequin capable of simulating any respiratory condition at the AI Summit. This AI-driven medical device aims to revolutionize pediatric emergency training by providing clinicians with realistic, programmable scenarios for rare lung pathologies.
AxoGen (NASDAQ: AXGN) has received a significant rating upgrade to "Strong-Buy" from Wells Fargo, signaling robust institutional confidence in the peripheral nerve repair specialist. This move, coupled with price target hikes from Jefferies and positive outlooks from Citigroup, underscores a bullish sentiment for the company's clinical and commercial trajectory.
iFabric Corp. has officially launched its Frontline line of clinically validated antimicrobial scrubs across a major Canadian wholesale club network. This move represents a significant shift for the company, moving its proprietary infection-control technology from specialized medical supply chains into high-volume retail environments.
NG Biotech and Hardy Diagnostics have received FDA Breakthrough Device Designation for two rapid diagnostic assays targeting multidrug-resistant pathogens. The NG-TEST Candida auris and NG-TEST Aci assays provide rapid, point-of-care identification of high-priority healthcare-associated infections.